Delivery Order SPE2DR25D3004-SPE2DR26FXMS4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,078.44 to AmerisourceBergen Drug Corp for Belbuca 150 mcg film (60 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) represents a routine pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $2,693.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 units of Belbuca 300 mcg film on November 13, 2025, with completion expected by November 14, 2025. This non-set-aside award represents a pharmaceutical supply delivery to support federal medical procurement needs. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $2,615.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for Belbuca 900 microgram films (60-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-competitive, non-set-aside award represents a small-value transaction typical of routine pharmaceutical supply replenishment. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Belbuca 300 mcg film (60-count), with a ceiling value of $1,075.23. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a $1,301.11 delivery order to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60 count) under a firm fixed price contract. The order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $1,168.12 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 MCG film (60 count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no...
- The Defense Logistics Agency awarded a $1,455.48 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 microgram film (60 count) on September 19, 2025, with completion targeted for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Belbuca 600 microgram films (60 count). This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,683.50 with firm fixed pricing and an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,635.46 by the Defense Logistics Agency on June 13, 2025, with an ultimate completion date of June 16, 2025. The contract, which carries no set-aside designation, calls for the delivery of Belbuca 300 microgram film (60 count), a buccal film formulation used for pain management. This delivery order is issued under...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXMS4Delivery Order
This delivery order, valued at $1,024.25, was awarded to AmerisourceBergen Drug Corp on November 20, 2025, by the Defense Logistics Agency (DLA) for the supply of Belbuca 600 mcg film in quantities of 60 units. The contract represents a firm fixed-price delivery order with an ultimate completion date of November 21, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. The DLA has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen alongside other qualified contractors to serve defense healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/20/25 |